COVID-19 and AKI: Where Do We Stand?

Palevsky, Paul M

Palevsky, Paul M.

Palevsky PM; Kidney Medicine Section, Medical Service, Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, Pennsylvania and Renal-Electrolye Division, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania palevsky@pitt.edu.

J Am Soc Nephrol ; 32(5): 1029-1032, 2021 05 03.

Article in English | MEDLINE | ID: covidwho-1105923

Subject(s)

Acute Kidney Injury/etiology; COVID-19/complications; SARS-CoV-2; Acute Kidney Injury/epidemiology; Acute Kidney Injury/therapy; COVID-19/epidemiology; Disease Progression; Humans; Pandemics; Renal Replacement Therapy; Risk Factors; SARS-CoV-2/pathogenicity

Keywords

COVID-19; SARS-CoV-2; acute kidney injury; kidney replacement therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Acute Kidney Injury / SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: J Am Soc Nephrol Journal subject: Nephrology Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google